Recombinant antibodies: A new application in scorpion envenomation?;Anticorps recombinants: Vers un renouveau de la sérothérapie anti-scorpionique?

Bulletin de la Societe de Pathologie Exotique

Volumn 98, Issue 5, 2005, Pages 383-385

  Muzard, J ^a   Billiald, P ^a,b   Goyffon, M ^a   Aubrey, N ^b  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Antivenom; Molecular engineering; Neurotoxin; Passive immunotherapy; Recombinant antibody; Scorpion

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FRAGMENT; MONOCLONAL ANTIBODY; NEUROTOXIN; RECOMBINANT PROTEIN; SCORPION VENOM;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; PASSIVE IMMUNIZATION; PROTEIN ENGINEERING; SCORPION; SPIDER BITE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ARACHNIDISM; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FRAGMENTS; NEUROTOXINS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; SCORPION VENOMS; SCORPIONS;

EID: 29944435403     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ADAMS GP & SCHIER R - Generating improved single-chain Fv molecules for tumor targeting. J Immunol Methods, 1999, 231, 249-260.
2. AUBREY N, DEVAUX C, SIZARET PY, ROCHAT H, GOYFFON M & BILLIALD P - Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin. Cell Mol Life Sci, 2003, 60, 617-628.
3. AUBREY A, MUZARD J, PETER JC, ROCHAT H, GOYFFON M et al. - Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI, and functional evaluation versus other antibody fragments. Toxicon, 2004, 43, 233-241.
4. BAHRAOUI E, PICHON J, MULLER JM, DARBON H, EL AYEB M, GRANIER C, MARVALDI J & ROCHAT H - Monoclonal antibodies to scorpion toxins. Characterization and molecular mechanisms of neutralization. J Immunol, 1988, 141, 214-220.
5. CLOT-FAYBESSE O, JUIN M, ROCHAT H & DEVAUX C - Monoclonal antibodies against the Androctonus australis Hector scorpion neurotoxin I: characterisation and use for venom neutralisation. FEBS Lett, 1999, 458, 313-318.
6. GOYFFON M, VACHON M & BROGLIO N - Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia. Toxicon, 1982, 20, 337-344.
7. JUAREZ-GONZALEZ VR, RIANO-UMBARILA L, QUINTERO-HERNANDEZ V, OLAMENDI-PORTUGAL T, ORTIZ-LEON M et al. - Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2. J Mol Biol, 2005, 346, 1287-1297.
8. LICEA AF, BECERRIL B & POSSANI LD - Fab fragments of the monoclonal antibody BCF2 are capable of neutralizing the whole soluble venom from the scorpion Centruroides noxius Hoffmann. Toxicon, 1996, 34, 843-847.
9. MARTIN MF & ROCHAT H - Large scale purification of toxins from the venom of the scorpion Androctonus australis Hector. Toxicon, 1986, 24, 1131-1139.
10. SCHILLBERG S, FISHER R, & EMANS N - Molecular farming of recombinant antibodies in plants. Cell Mol Life Sci, 2003, 60, 433-445.
11. SELISKO B, COSIO G, GARCIA C, BECERRIL B, POSSANI LD & HORJALES E - Bacterial expression, purification and functional characterization of a recombinant chimeric Fab derived from murine mAb BCF2 that neutralizes the venom of the scorpion Centruroides noxius Hoffmann. Toxicon, 2004, 43, 43-51.
12. STACY KM - Therapeutic Mabs: Saving lives and making billions. The Scientist, 2005, 19, 17-19.
13. THEAKSTON RD, WARRELL DA & GRIFFITHS E - Report of a WHO workshop on the standardization and control of antivenoms. Toxicon, 2003, 41, 541-557.
14. ZAHND C, SPINELLI S, LUGINBUHL B, AMSTUTZ P, CAMBILLAU C & PLUCKTHUN A - Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity. J Biol Chem, 2004, 279, 18870-18877.